N28.85
Pyeloureteritis cystica
Clinical Classification Guidelines
Medical Intelligence & Overview
Pyeloureteritis cystica is a rare, benign condition characterized by the formation of small, cyst-like structures within the lining of the renal pelvis and ureter. These cysts are typically an outcome of chronic inflammation or irritation of the urinary tract, often associated with infections or other underlying urinary system disorders. Although the condition can be discovered incidentally during imaging tests, understanding its features, causes, symptoms, and management options is essential for patients and healthcare professionals alike.
Causes & Symptoms
Clinical Causes: Chronic urinary tract infections (UTIs) Repeated episodes of kidney inflammation (interstitial nephritis) Obstruction of the urinary tract leading to persistent irritation Ureteral or kidney stones causing irritation and inflammation Chronic use of certain medications that may irritate the urinary tract Underlying urinary tract anomalies or congenital conditions
Key Symptoms: Often asymptomatic and discovered incidentally during imaging Flank pain or discomfort, especially if associated with infections Hematuria (blood in the urine) Frequent urinary tract infections Pain or discomfort during urination Changes in urinary habits, such as increased urgency or frequency Possible signs of urinary obstruction if severe
Diagnostic & Treatment
Diagnosis Path: Diagnosis is primarily made through imaging techniques such as ultrasound, computed tomography (CT) scan, or intravenous pyelography. These tests can reveal characteristic cystic formations within the renal pelvis and ureter. A definitive diagnosis may require a cystoscopy or biopsy to distinguish this condition from other cystic or tumorous processes within the urinary tract. Laboratory tests, including urinalysis, can help identify associated infections or signs of inflammation. Since pyeloureteritis cystica is benign, the focus is on ruling out other more serious conditions.
Treatment Protocols: Treatment options depend on the severity of symptoms and any underlying causes. In cases where the condition is asymptomatic and discovered incidentally, active surveillance may be sufficient. For symptomatic cases or those with underlying infections or obstructions, management may include: - Addressing infections with appropriate antibiotics - Treating any obstructive stones or structural abnormalities - Monitoring with periodic imaging studies to detect changes or progression - Interventions like ureteral stenting or surgical procedures if significant obstruction or complications arise Overall, managing underlying conditions and preventing recurrent irritation are key to controlling pyeloureteritis cystica.
Clinical Advice & FAQs
Billing Guidance
Is N28.85 a billable ICD-10 code?
Yes, N28.85 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N28.85?
Clinical documentation must specify the nature of Pyeloureteritis cystica and any associated comorbidities for accurate reporting.
Cite this Clinical Reference